These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 23149705)

  • 1. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
    Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
    Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indurated Plaques on the Legs: Think Lymphoma.
    Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
    Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
    Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
    Kempf W; Kazakov DV; Mitteldorf C
    Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
    Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
    J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes.
    Lucioni M; Pescia C; Bonometti A; Fraticelli S; Moltrasio C; Ramponi A; Riboni R; Roccio S; Ferrario G; Arcaini L; Goteri G; Berti E; Paulli M
    Hum Pathol; 2021 May; 111():1-9. PubMed ID: 33548250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
    Wilcox RA
    Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.
    Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV
    Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
    Koens L; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management.
    Fava P; Roccuzzo G; Alberti-Violetti S; Grandi V; Pileri A; Pimpinelli N; Berti E; Quaglino P
    Presse Med; 2022 Mar; 51(1):104109. PubMed ID: 35026390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.
    Demirkesen C; Tüzüner N; Esen T; Lebe B; Ozkal S
    Leuk Res; 2011 Sep; 35(9):1269-72. PubMed ID: 21700336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-1 expression in cutaneous B-cell lymphoma.
    Çetinözman F; Koens L; Jansen PM; Willemze R
    J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
    Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
    Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
    Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
    Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.